Status:
TERMINATED
A Study of Electromagnetic Waves in the Treatment of the Advanced Hepatocarcinoma
Lead Sponsor:
Pasche, Boris, M.D.
Collaborating Sponsors:
Barbault, Alexandre, M.S.
Conditions:
Carcinoma, Hepatocellular
Eligibility:
All Genders
18-95 years
Phase:
PHASE2
Brief Summary
Hepatocarcinoma (HCC) is the first cause of deaths due to cancer worldwide. More than one million two hundred thousand new patients are diagnosed each year. The prognosis of patients suffering from ad...
Detailed Description
Hepatocarcinoma (HCC) is the first cause of deaths due to cancer worldwide. More than one million two hundred thousand new patients are diagnosed each year. The prognosis of patients suffering from ad...
Eligibility Criteria
Inclusion
- The patients must have a diagnosis of inoperable hepatocellular carcinoma.
- The patients who have an AFP level higher than 400 ng/ml and an appearance characteristic of cancer of the liver do not need histological confirmation. These patients must however have a negative serology for the antigen of surface of hepatitis B If serology for this antigen is positive, they must have a rate of AFP higher than 4000 ng/ml.
- Presence of one or more lesions measurable(s) according to criteria's RECIST.
Exclusion
- Other anti-cancer treatments are not authorized during this study.
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00440934
Start Date
February 1 2007
End Date
December 1 2007
Last Update
May 6 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cabinet Médical de l'Avenue de la gare 6
Lausanne, Canton of Vaud, Switzerland, 1003